Caxton Associates (New York)’s Moderna MRNA Stock Holding History

Caxton Associates (New York)’s Portfolio MRNA Stock Details MRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell
2023 Q1	$399K	Sell
2022 Q4	$43M	Buy
2022 Q3	$28.2M	Buy
2022 Q2	$33.7M	Buy
2022 Q1	$29.1M	Buy
2021 Q4	$16.3M	Sell
2021 Q3	$24.9M	Buy
2021 Q2	$804K	Sell
2021 Q1	$560K	Buy